Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ivy

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Chest|December 24, 2005
Regulation and functions of the paired-related homeobox gene PRX1 in pulmonary vascular development and diseaseK Ihida-Stansbury, D M McKean, S A Gebb, et al.
Pulmonary Circulation|May 6, 2022
Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severityMelanie K Nies, Jun Yang, Megan Griffiths, et al.
Neurogenetics|October 16, 2008
Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome)C D Coldren, Z Lai, P Shragg, et al.
Pulmonary Circulation|May 8, 2023
Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survivalGuillermo Torres, Jun Yang, Megan Griffiths, et al.
International Journal of Cardiology|November 20, 2015
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)M Beghetti, I Schulze-Neick, R M F Berger, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
The European Respiratory Journal|February 8, 2020
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertensionCatherine E Simpson, Jenny Y Chen, Rachel L Damico, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Chest|December 24, 2005
Regulation and functions of the paired-related homeobox gene PRX1 in pulmonary vascular development and diseaseK Ihida-Stansbury, D M McKean, S A Gebb, et al.
Pulmonary Circulation|May 6, 2022
Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severityMelanie K Nies, Jun Yang, Megan Griffiths, et al.
Neurogenetics|October 16, 2008
Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome)C D Coldren, Z Lai, P Shragg, et al.
Pulmonary Circulation|May 8, 2023
Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survivalGuillermo Torres, Jun Yang, Megan Griffiths, et al.
International Journal of Cardiology|November 20, 2015
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension)M Beghetti, I Schulze-Neick, R M F Berger, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
Chest|August 18, 2024
Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk ModelsMegan Griffiths, Catherine E Simpson, Jun Yang, et al.
The European Respiratory Journal|February 8, 2020
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertensionCatherine E Simpson, Jenny Y Chen, Rachel L Damico, et al.
Pageof 11